Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FCKFQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,344
Award facts
- Contract value 100% obligated
- $2,343.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors. This firm fixed-price, non-set-aside contract was executed on September 23, 2025, with an ultimate completion date of October 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle extending through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this requirement. The contract reflects the company's established role as a primary supplier of specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains for the Defense Health Agency and broader military healthcare systems. DLA's Medical Supply Chain continues to leverage AmerisourceBergen's capabilities as part of its strategic pharmaceutical prime vendor approach, which contemplates multiple regional awards to ensure comprehensive global medical supply coverage for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DB25FCKFQ?
SPE2DB25FCKFQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FCKFQ worth?
The government has obligated $2,344 on SPE2DB25FCKFQ.
Is contract SPE2DB25FCKFQ an order under another contract?
Yes. SPE2DB25FCKFQ is a delivery order under SPE2DB24D2013, an indefinite delivery contract.
Was contract SPE2DB25FCKFQ competed?
The extent of competition for SPE2DB25FCKFQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award